Evidence map›Paper›PMID 35832625›Full record

ArticleComputational and structural biotechnology journal2022

Identifies microtubule-binding protein

Wenwen Wang, Jingjing Zhang, Yuqing Wang, Yasi Xu, Shirong Zhang

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wenwen WangTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Jingjing ZhangTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Yuqing WangTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Yasi XuTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Shirong ZhangTranslational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.
Hangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Centrosome and spindle pole-associated protein (

Indexed as

ACC, adrenocortical carcinomaBiomarkerBP, biological pathwaysBRCA, breast invasive carcinomaCAF, cancer-associated fibroblastsCC, cellular componentCESC, cervical squamous cell carcinoma and endocervical adenocarcinomaCHOL, cholangiocarcinomaC-index, concordance indexCNA, copy number alterationCOAD, colon adenocarcinomaCPTAC, Clinical Proteomic Tumor Analysis ConsortiumCSPP1CSPP1, centrosome and spindle pole-associated proteinCTL, cytotoxic T lymphocyteDEGs, differentially expressed genesDLBC, diffuse large B-cell lymphomaDSS, disease-specific survivalEMT, epithelial-mesenchymal transitionENCORI, Encyclopedia of RNA InteractomesESCA, esophageal carcinomaFAG, ferroptosis-associated geneFDG, ferroptosis-driver geneFerroptosisFSG, ferroptosis-suppressor geneGBM, glioblastoma multiformeGO, Gene OntologyGSEA, Gene Set Enrichment AnalysisGSVA, gene set variation analysisGTEx, Genotype-Tissue ExpressionHNSC, head and neck squamous cell carcinomaICB, immune checkpoint blockadeKEGG, Kyoto Encyclopedia of Genes and GenomesKICH, kidney chromophobeKIRC, renal clear cell carcinomaKM, Kaplan-MeierLAML, acute myeloid leukemiaLGG, low-grade gliomasLIHC, liver hepatocellular carcinomaLUAD, lung adenocarcinomaLUSC, lung squamous cell carcinomaMF, molecular functionsMHC, major histocompatibility complexMSI, microsatellite instabilityOS, overall survivalOV, ovarian serous cystadenocarcinomaPAAD, pancreatic adenocarcinomaPan-cancerPFI, progression-free intervalPFS, progression-free survivalPRAD, prostate cancerREAD, rectum adenocarcinomaROC, receiver operating characteristicsSKCM, skin cutaneous melanomaTCGA, The Cancer Genome AtlasTGCT, testicular germ cell tumors, STAD, stomach adenocarcinomaTHCA, thyroid cancerTHYM, thymomaTIDE, Tumor Immune Dysfunction and ExclusionTIMER, Tumor Immune Estimation ResourceTISIDB, Tumor-Immune System Interactions DataBaseTMB, tumor mutation burdenTME, tumor microenvironmentTumor microenvironmentUCEC, endometrial cancer uterine corpus endometrial carcinomaUCS, uterine carcinosarcoma

Identifiers

PMID35832625
PMCPMC9253833
OpenAlexW4283466264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.